Fundraising FoxS2 Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Rev Genomicsrevgenomics.cominSeed · Apr 2019
Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks.
AgTechBiotechHealthtechMedical DevicesSan Francisco, US
Bertrand Vick(CEO)inRobert John Markelz(Executive Officer, Director, Promoter)Gloria E Webster(Director, Promoter)Robert Markelz(Vice President of Genomics)
Co-investorsY CombinatorMerida Capital HoldingsAdditionAgrolimen VenturesFloret VenturesGron Ventures, Llc+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.